Skip to content
PICO Portalanswers from OpenAlex

Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis

PaperCitations, authors & open-access status

Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis have?

PICO Portalcitation count

Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis has 18 citations in the OpenAlex counts PICO Portal stores.

When was Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis published?

PICO Portalyear

Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis has 2010 year in the PICO Portal index.

What is the open-access status of Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis?

PICO Portaloa status

Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis has bronze oa status in the PICO Portal index.

What is the DOI of Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis?

PICO Portaldoi

The DOI for Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis is on the source record.

What is the PMID of Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis?

PICO Portalpmid

The PMID for Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis is on the source record.

What is the OpenAlex record for Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis?

PICO Portalopenalex

The OpenAlex for Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial